BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10614920)

  • 1. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
    Dietlein M; Dederichs B; Weigand A; Schicha H
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S190-4. PubMed ID: 10614920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine treatment of juvenile Graves disease.
    Foley TP; Charron M
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():61-5. PubMed ID: 9439919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (131)I and thyroid-associated ophthalmopathy.
    Rasmussen AK; Nygaard B; Feldt-Rasmussen U
    Eur J Endocrinol; 2000 Aug; 143(2):155-60. PubMed ID: 10913933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
    Salvatore D; Fenzi G
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioiodine therapy of Graves' disease--quality assurance and radiation protection].
    Reiners C
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():61-6. PubMed ID: 10355053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy.
    Perros P; Kendall-Taylor P; Neoh C; Frewin S; Dickinson J
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5321-3. PubMed ID: 15985483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health effects of therapeutic use of 131I in hyperthyroidism.
    Pauwels EK; Smit JW; Slats A; Bourguignon M; Overbeek F
    Q J Nucl Med; 2000 Dec; 44(4):333-9. PubMed ID: 11302261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R; Séra T; Valkusz Z; Julesz J; Csernay L; Pávics L
    Orv Hetil; 1999 Jun; 140(23):1291-5. PubMed ID: 10412264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid associated orbitopathy--medication, radioiodine or operation?
    Czarnywojtek A; Zgorzalewicz-Stachowiak M; Stangierski A; Florek E; Zdanowska J; Katarzyna H; Andrzejewska M; Ruchała M
    Przegl Lek; 2012; 69(10):1140-3. PubMed ID: 23421110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.